G Liu1,2, L Liang3, G A Bray4, L Qi1,5,6, F B Hu1,6, J Rood4, F M Sacks1,6, Q Sun1,6. 1. Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA, USA. 2. Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China. 3. Department of Epidemiology and Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, USA. 4. Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA. 5. Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA. 6. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: The role of thyroid hormones in diet-induced weight loss and subsequent weight regain is largely unknown. OBJECTIVES: To examine the associations between thyroid hormones and changes in body weight and resting metabolic rate (RMR) in a diet-induced weight loss setting. SUBJECTS/ METHODS: Data analysis was conducted among 569 overweight and obese participants aged 30-70 years with normal thyroid function participating in the 2-year Prevention of Obesity Using Novel Dietary Strategies (POUNDS) LOST randomized clinical trial. Changes in body weight and RMR were assessed during the 2-year intervention. Thyroid hormones (free triiodothyronine (T3), free thyroxine (T4), total T3, total T4 and thyroid-stimulating hormone (TSH)), anthropometric measurements and biochemical parameters were assessed at baseline, 6 months and 24 months. RESULTS: Participants lost an average of 6.6 kg of body weight during the first 6 months and subsequently regained an average of 2.7 kg of body weight over the remaining period from 6 to 24 months. Baseline free T3 and total T3 were positively associated, whereas free T4 was inversely associated, with baseline body weight, body mass index and RMR. Total T4 and TSH were not associated with these parameters. Higher baseline free T3 and free T4 levels were significantly associated with a greater weight loss during the first 6 months (P<0.05) after multivariate adjustments including dietary intervention groups and baseline body weight. Comparing extreme tertiles, the multivariate-adjusted weight loss±s.e. was -3.87±0.9 vs -5.39±0.9 kg for free T3 (Ptrend=0.02) and -4.09±0.9 vs -5.88±0.9 kg for free T4 (Ptrend=0.004). The thyroid hormones did not predict weight regain in 6-24 months. A similar pattern of associations was also observed between baseline thyroid hormones and changes in RMR. In addition, changes in free T3 and total T3 levels were positively associated with changes in body weight, RMR, body fat mass, blood pressure, glucose, insulin, triglycerides and leptin at 6 months and 24 months (all P<0.05). CONCLUSIONS: In this diet-induced weight loss setting, higher baseline free T3 and free T4 predicted more weight loss, but not weight regain among overweight and obese adults with normal thyroid function. These findings reveal a novel role of thyroid hormones in body weight regulation and may help identify individuals more responsive to weight loss diets.
RCT Entities:
BACKGROUND: The role of thyroid hormones in diet-induced weight loss and subsequent weight regain is largely unknown. OBJECTIVES: To examine the associations between thyroid hormones and changes in body weight and resting metabolic rate (RMR) in a diet-induced weight loss setting. SUBJECTS/ METHODS: Data analysis was conducted among 569 overweight and obeseparticipants aged 30-70 years with normal thyroid function participating in the 2-year Prevention of Obesity Using Novel Dietary Strategies (POUNDS) LOST randomized clinical trial. Changes in body weight and RMR were assessed during the 2-year intervention. Thyroid hormones (freetriiodothyronine (T3), freethyroxine (T4), total T3, total T4 and thyroid-stimulating hormone (TSH)), anthropometric measurements and biochemical parameters were assessed at baseline, 6 months and 24 months. RESULTS:Participants lost an average of 6.6 kg of body weight during the first 6 months and subsequently regained an average of 2.7 kg of body weight over the remaining period from 6 to 24 months. Baseline freeT3 and total T3 were positively associated, whereas free T4 was inversely associated, with baseline body weight, body mass index and RMR. Total T4 and TSH were not associated with these parameters. Higher baseline freeT3 and free T4 levels were significantly associated with a greater weight loss during the first 6 months (P<0.05) after multivariate adjustments including dietary intervention groups and baseline body weight. Comparing extreme tertiles, the multivariate-adjusted weight loss±s.e. was -3.87±0.9 vs -5.39±0.9 kg for freeT3 (Ptrend=0.02) and -4.09±0.9 vs -5.88±0.9 kg for free T4 (Ptrend=0.004). The thyroid hormones did not predict weight regain in 6-24 months. A similar pattern of associations was also observed between baseline thyroid hormones and changes in RMR. In addition, changes in freeT3 and total T3 levels were positively associated with changes in body weight, RMR, body fat mass, blood pressure, glucose, insulin, triglycerides and leptin at 6 months and 24 months (all P<0.05). CONCLUSIONS: In this diet-induced weight loss setting, higher baseline freeT3 and free T4 predicted more weight loss, but not weight regain among overweight and obese adults with normal thyroid function. These findings reveal a novel role of thyroid hormones in body weight regulation and may help identify individuals more responsive to weight loss diets.
Authors: Laura P Svetkey; Victor J Stevens; Phillip J Brantley; Lawrence J Appel; Jack F Hollis; Catherine M Loria; William M Vollmer; Christina M Gullion; Kristine Funk; Patti Smith; Carmen Samuel-Hodge; Valerie Myers; Lillian F Lien; Daniel Laferriere; Betty Kennedy; Gerald J Jerome; Fran Heinith; David W Harsha; Pamela Evans; Thomas P Erlinger; Arline T Dalcin; Janelle Coughlin; Jeanne Charleston; Catherine M Champagne; Alan Bauck; Jamy D Ard; Kathleen Aicher Journal: JAMA Date: 2008-03-12 Impact factor: 56.272
Authors: Marion J Franz; Jeffrey J VanWormer; A Lauren Crain; Jackie L Boucher; Trina Histon; William Caplan; Jill D Bowman; Nicolas P Pronk Journal: J Am Diet Assoc Date: 2007-10
Authors: Peter N Taylor; Rebecca Richmond; Neil Davies; Adrian Sayers; Kirsty Stevenson; Wolfram Woltersdorf; Andrew Taylor; Alix Groom; Kate Northstone; Susan Ring; Onyebuchi Okosieme; Aled Rees; Dorothea Nitsch; Graham R Williams; George Davey Smith; John W Gregory; Nicholas J Timpson; Jonathan H Tobias; Colin M Dayan Journal: J Clin Endocrinol Metab Date: 2015-11-23 Impact factor: 5.958
Authors: Lena Bjergved; Torben Jørgensen; Hans Perrild; Peter Laurberg; Anne Krejbjerg; Lars Ovesen; Lone Banke Rasmussen; Nils Knudsen Journal: PLoS One Date: 2014-04-11 Impact factor: 3.240
Authors: Gang Liu; Klodian Dhana; Jeremy D Furtado; Jennifer Rood; Geng Zong; Liming Liang; Lu Qi; George A Bray; Lilian DeJonge; Brent Coull; Philippe Grandjean; Qi Sun Journal: PLoS Med Date: 2018-02-13 Impact factor: 11.069
Authors: Min Joo Kim; Sun Wook Cho; Sumin Choi; Dal Lae Ju; Do Joon Park; Young Joo Park Journal: Int J Endocrinol Date: 2018-05-03 Impact factor: 3.257
Authors: Paula Juiz-Valiña; María Cordido; Elena Outeiriño-Blanco; Sonia Pértega; Bárbara María Varela-Rodríguez; María Jesús García-Brao; Enrique Mena; Lara Pena-Bello; Susana Sangiao-Alvarellos; Fernando Cordido Journal: J Clin Med Date: 2020-01-28 Impact factor: 4.241
Authors: Valentina Capelli; Carmen Grijota-Martínez; Nathalia R V Dragano; Eval Rial-Pensado; Johan Fernø; Rubén Nogueiras; Jens Mittag; Carlos Diéguez; Miguel López Journal: Nutrients Date: 2021-11-24 Impact factor: 5.717